Skip to main content

Table 3 Patient baseline demographic and clinical characteristics

From: Efficacy, safety and tolerability of escitalopram in doses up to 50 mg in Major Depressive Disorder (MDD): an open-label, pilot study

Characteristic

n = 60

Female, n (%)

52 (86.7%)

White, n (%)

60 (100%)

Age, mean (SD), years

43.5 (10.7)

BMI, mean (SD), kg/m2

30.8 (7.9)

Duration of current MDD episode, mean (SD), months a

18.9 (20.2)

Other psychiatric history, n (%)

42 (70.0%)

MADRS score, n (%)

 

   13 - 20

15 (25.0%)

   21 - 25

14 (23.3%)

   26 - 30

19 (31.7%)

   ≥31

12 (20.0%)

MADRS score, mean (SD)

25.7 (6.31)

CGI-S score, n (%)

 

   3 - Mildly ill

1 (1.7%)

   4 - Moderately ill

32 (53.3%)

   5 - Markedly ill

22 (36.7%)

   6 - Severely ill

5 (8.3%)

   7 - Among the most extremely ill patients

0 (0.0%)

  1. a n = 59